[The expression and significance of IGF1R-Ras/RAGE-HMGB1 pathway in colorectal cancer patients with type 2 diabetes mellitus].

Objective: To investigate the expression of IGF1R-Ras and RAGE-HMGB1 signaling pathways in colorectal cancer patients with type 2 diabetes mellitus and their significance. Methods: The resected cancer tissues were obtained from 59 patients with colorectal cancer (CRC), including 29 patients with type 2 diabetes mellitus (CRC/DM group) and 30 with CRC alone (CRC group). The expressions of IGF1R, Ras, RAGE and HMGB1 in cancer tissues were detected by immunohistochemistry. The differences between the two groups were compared and the relationship between the expression and clinicopathological characteristics was analyzed. Results: In CRC/DM group, the positive rates of IGF1R and Ras were both 65.5% (19/29), and 51.7% (15/29) patients had IGF1R+ Ras+ immunophenotype, which were significantly higher than those in CRC group [33.3% (10/30), 36.7% (11/30) and 20.0% (6/30); P=0.013, 0.027 and 0.011, respectively]. The expression of IGF1R and Ras in CRC / DM group was positively correlated (r=0.479, P=0.017). The positive rate of RAGE expression in CRC group and CRC/DM group was 70.0% (21/30) and 72.4% (21/29) respectively, and the positive rate of HMGB1 expression was 46.7% (14/30) and 58.6% (17/29) respectively, neither was observed with significant difference (P=0.358 and 0.838). However, the proportion of patients with RAGE+ HMGB1+ immunophenotype in CRC/DM group [55.2% (16/29)] was higher than that in CRC Group [26.7% (8/30)] which was statistically significant (P=0.026), and the expression of both proteins was positively correlated in CRC/DM group (r=0.578, P=0.003). The clinicopathological analysis showed that in both groups the expression of IGF1R, Ras, RAGE and HMGB1 had no correlation with the sex, age, differentiation degree, tumor length, T stage and lymph node metastasis (P>0.05). Conclusion: Both IGF1R-Ras and RAGE-HMGB1 pathways may be involved in the oncogenesis of colorectal cancer in patients with type 2 diabetes.

[Clinical significance of FOXM1 and Gli-1 protein expression in high-grade ovarian serous carcinoma].

Objective: To investigate the different expression and prognostic significance of forkhead box M1 (FOXM1) and Gli-l in ovarian high grade serous carcinoma (HGSC). Methods: The expressions of FOXM1 and Gli-1 in 94 cases of HGSC and 20 cases of normal fallopian tube tissues were detected by immunohistochemistry. Kaplan-Meier analysis and Cox multivariate survival analysis were used to assess the relationship of the FOXM1 and Gli-1 levels with age, International Federation of Gynecology and Obstetrics (FIGO) stage, omental metastasis, and residual foci and prognosis of HGSC. Results: The positive rates of FOXM1 and Gli-1 expression in HGSC were 79.8% (75/94) and 77.7% (73/94), respectively, both significantly higher than those of the normal controls (P<0.05). The expressions of FOXM1 and Gli-1 were significantly correlated with FIGO stage, and both of their positive rates in stage Ⅲ-Ⅳpatients were significantly higher than those in stage Ⅰ-Ⅱ cases (P<0.001). The expressions of FOXM1 in HGSC were positively correlated with Gli-1.Kaplan-Meier analysis revealed that the 5-year overall survival rates of FOXM1- and Gli-1-positive groups were 8.0% and 6.8%, significantly lower than 36.8% and 38.1% of the FOXM1- and Gli-1-negative groups, respectively (P<0.05 for both). Cox multivariate survival analysis revealed that FIGO stage and overexpression of FOXM1 protein were independent prognostic factors of HGSC patients (P<0.05 for both). Conclusions: The overexpression of FOXM1 and Gli-1 proteins participate in the carcinogenesis of HGSC, and are significantly associated with FIGO stage. The protein expression of FOXM1 is positively correlated with Gli-1 in HGSC. Expression of FOXM1 protein and FIGO stage are independent prognostic factors of HGSC.

Effect of tricalcium aluminate on the properties of tricalcium silicate-tricalcium aluminate mixtures: setting time, mechanical strength and biocompatibility.

AIM: To prepare biphasic mixtures by adding Ca(3) Al(2) O(6) into Ca(3) SiO(5) and to evaluate the effect of Ca(3) Al(2) O(6) on physical and ex vivo biological properties of the Ca(3) SiO(5) /Ca(3) Al(2) O(6) mixtures derived from mineral trioxide aggregate (MTA). METHODOLOGY: Combinations of Ca(3) SiO(5) and Ca(3) Al(2) O(6) (0, 5%, 10% and 15%) powders were mixed with deionized water. After hydration, setting time, compressive strength, ex vivo bioactivity and biocompatibility of each mixture were investigated and compared to pure Ca(3) SiO(5) . RESULTS: With the addition of Ca(3) Al(2) O(6) from 0% to 15%, the initial setting time and final setting time of the Ca(3) SiO(5) /Ca(3) Al(2) O(6) mixtures decreased from 110 to 43min and from 220 to 97min, respectively (P≤0.05). However, the compressive strength increased from 6.75 to 16.20MPa after one day (P≤0.05) and from 17.73 to 29.13 Mpa after 28 days. Furthermore, the mixtures with 10% Ca(3) Al(2) O(6) or less had similar bioactivity and biocompatibility when compared to the pure Ca(3) SiO(5). CONCLUSIONS: The addition of Ca(3) Al(2) O(6) into Ca(3) SiO(5) accelerated the hydration process, reduced the setting time and improved the compressive strength. Furthermore, these mixtures were bioactive and biocompatible and had a stimulatory effect on the L929 cell growth when the content of Ca(3) Al(2) O(6) was below 10%. Therefore, the mixtures with 10% Ca(3) Al(2) O(6) produced the best compromise between hydration and ex vivo biological properties.

[Determination of naoning pian by multi-wavelength linear regression method].

Assay of naoning pian was reported by multi-wavelength linear regression method in this paper. The program was edited by BASIC. The recoveries and RSD of pyramidon and caffeine were 98.03%-100.9%, 1.0% and 97.77%-99.39%, 0.61%, respectively. This method could be used for the determination of two components in naoning pian without separation. The method was simple, rapid, and results were satisfactory.